H-Index
70
Scimago Lab
powered by Scopus
Clarivate
Analytics
Formerly the IP & Science
business of Thomson Reuters

Logo




eISSN: 1643-3750

Get your full text copy in PDF

Influence of systemic photochemotherapy on regulatory T cells and selected cytokine production in psoriatic patients: a pilot study.

Anna Zalewska, Ewa Trznadel-Budźko, Przemysław Lewkowicz, Małgorzata Banasik, Henryk Tchórzewski, Ewa Głowacka

Med Sci Monit 2005; 11(12): CR594-598

ID: 438858


Background: Psoriasis is a chronic autoimmune inflammatory disease of theskin with strong genetic and environmental risk factors and is regarded as a Th1 cell-type disease. Theaim of our study was to evaluate the effect of one-month PUVA (Psoralen Ultraviolet A) therapy on a regulatoryT-cell subpopulation (CD4+CD25+) and the production of some cytokines. Material/Methods: The study wasperformed on the group of 12 patients with severe psoriasis. They were put on PUVA therapy for one month.We analyzed the level of CD4+CD25+ regulatory T cells using a FACSCalibur cytometer and CellQuest Software.The production of IFN-gamma (interferon-gamma), TNF-alpha (tumor necrosis factor alpha), IL (interleukin)-10, IL-5, IL-4, and IL-2 by lymphocytes was estimated by using a CBA system. The control group consistedof 11 healthy volunteers. Results: We found that the production of INF-gamma, TNF-alpha, IL-2, and IL-10in psoriatic patients before PUVA application increased significantly compared with the control group.In patients after PUVA therapy we observed decreased production of TNF-alpha and a decreased number ofCD4+CD25+ cells in the blood compared with the same group of patients before the treatment. Conclusions:It was demonstrated that systemic PUVA therapy led to a marked reduction in CD4+CD25+ T cells and a changein cytokine production.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree